The Kaplan–Meier curves of overall survival (OS), disease-specific survival (DSS) and progression-free interval (PFI) in glioma patients were plotted to clarify the prognostic value of LYRM4-AS1 expression. This evidence concerns the gene LYRM4 and glioma.